Anna Ludovica FRACANZANI
Anna Ludovica FRACANZANI
Associate Professor of Internal Medicine
Verified email at
Cited by
Cited by
Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes
AL Fracanzani, L Valenti, E Bugianesi, M Andreoletti, A Colli, E Vanni, ...
Hepatology 48 (3), 792-798, 2008
Homozygosity for the patatin‐like phospholipase‐3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease
L Valenti, A Al‐Serri, AK Daly, E Galmozzi, R Rametta, P Dongiovanni, ...
Hepatology 51 (4), 1209-1217, 2010
Genomewide association study of severe Covid-19 with respiratory failure
Severe Covid-19 GWAS Group
New England Journal of Medicine 383 (16), 1522-1534, 2020
Tumor necrosis factor α promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease
L Valenti, AL Fracanzani, P Dongiovanni, G Santorelli, A Branchi, E Taioli, ...
Gastroenterology 122 (2), 274-280, 2002
Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association
S Fargion, A Piperno, MD Cappellini, M Sampietro, AL Fracanzani, ...
Hepatology 16 (6), 1322-1326, 1992
Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease
P Dongiovanni, S Petta, C Maglio, AL Fracanzani, R Pipitone, E Mozzi, ...
Hepatology 61 (2), 506-514, 2015
Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study
L Valenti, AL Fracanzani, P Dongiovanni, E Bugianesi, G Marchesini, ...
American Journal of Gastroenterology 102 (6), 1251-1258, 2007
Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis
S Fargion, M Mattioli, AL Fracanzani, M Sampietro, D Tavazzi, P Fociani, ...
The American journal of gastroenterology 96 (8), 2448-2455, 2001
Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target
P Dongiovanni, AL Fracanzani, S Fargion, L Valenti
Journal of hepatology 55 (4), 920-932, 2011
Carotid artery intima-media thickness in nonalcoholic fatty liver disease
AL Fracanzani, L Burdick, S Raselli, P Pedotti, L Grigore, G Santorelli, ...
The American journal of medicine 121 (1), 72-78, 2008
Patatin‐like phospholipase domain‐containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C
L Valenti, MG Rumi, E Galmozzi, A Aghemo, B Del Menico, S De Nicola, ...
Hepatology 53 (3), 791-799, 2011
Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non–iron‐related chronic liver disease
AL Fracanzani, D Conte, M Fraquelli, E Taioli, M Mattioli, A Losco, ...
Hepatology 33 (3), 647-651, 2001
HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease
L Valenti, AL Fracanzani, E Bugianesi, P Dongiovanni, E Galmozzi, ...
Gastroenterology 138 (3), 905-912, 2010
Surival and prognostic factors in 212 Italian patients with genetic hemochromatosis
S Fargion, C Mandelli, A Piperno, B Cesana, AL Fracanzani, M Fraquelli, ...
Hepatology 15 (4), 655-659, 1992
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ...
The Lancet 394 (10215), 2184-2196, 2019
Impact of large regenerative, low grade and high grade dysplastic nodules in hepatocellular carcinoma development
M Borzio, S Fargion, F Borzio, AL Fracanzani, AM Croce, T Stroffolini, ...
Journal of hepatology 39 (2), 208-214, 2003
High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda
M Sampietro, A Piperno, L Lupica, C Arosio, A Vergani, N Corbetta, ...
Hepatology 27 (1), 181-184, 1998
Nonalcoholic fatty liver disease and vascular disease: state-of-the-art
S Fargion, M Porzio, AL Fracanzani
World Journal of Gastroenterology: WJG 20 (37), 13306, 2014
Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease
P Dongiovanni, L Valenti, R Rametta, AK Daly, V Nobili, E Mozzi, ...
Gut 59 (2), 267-273, 2010
Increased expression and activity of the transcription factor FOXO1 in nonalcoholic steatohepatitis
L Valenti, R Rametta, P Dongiovanni, M Maggioni, AL Fracanzani, ...
Diabetes 57 (5), 1355-1362, 2008
The system can't perform the operation now. Try again later.
Articles 1–20